Dr Reddy's Labs Raised to Buy From Sell by Citigroup
Ratings actions from Benzinga: GMT) Dr Reddy's Labs Price Target Raised to $1450.00/Share From $1040.00 by CitigroupRatings actions from Benzinga
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.